In 2024, three breast cancer multidisciplinary meetings (MDT) were held, with one more scheduled for December. During these meetings, seven new cases were discussed, along with updates on ongoing clinicals trials in the field.
The working group, led by Dr. Liana Safaryan from Yeolyan Hematology and Oncology Center, conducts case discussions on difficult breast cancer cases with the help of Dr Nathaniel Boughanim, Dr Sarkis Meterissian, and Dr Tarek Hijal from McGill University, Canada. The group also runs discussions based on case simulations and hypothetical scenarios, discussing histotype and latest advances.
Find more about the Breast Cancer Working Group.
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048